CAFs originate from regular fibroblasts upon activation, primarily through transforming growth factor-β (TGF-β) and stromal cell-derived factor-1 (SDF-1) from cancer cells, and comprise a significant portion of the TME [60,61]. This evidence concerns the gene CXCL12 and cancer.